PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $200,869 | -16.0% | 4,939 | 0.0% | 0.03% | -23.7% |
| Q1 2023 | $239,245 | -3.5% | 4,939 | 0.0% | 0.04% | -19.1% |
| Q3 2022 | $248,000 | +3.8% | 4,939 | -23.0% | 0.05% | +27.0% |
| Q1 2022 | $239,000 | -6.3% | 6,413 | 0.0% | 0.04% | -2.6% |
| Q4 2021 | $255,000 | +6.7% | 6,413 | 0.0% | 0.04% | -2.6% |
| Q3 2021 | $239,000 | -11.8% | 6,413 | 0.0% | 0.04% | -11.4% |
| Q2 2021 | $271,000 | -10.9% | 6,413 | 0.0% | 0.04% | -18.5% |
| Q1 2021 | $304,000 | -22.3% | 6,413 | 0.0% | 0.05% | -28.0% |
| Q4 2020 | $391,000 | +30.3% | 6,413 | 0.0% | 0.08% | +13.6% |
| Q3 2020 | $300,000 | -7.7% | 6,413 | 0.0% | 0.07% | -18.5% |
| Q2 2020 | $325,000 | +13.6% | 6,413 | 0.0% | 0.08% | -8.0% |
| Q1 2020 | $286,000 | -7.1% | 6,413 | 0.0% | 0.09% | +15.8% |
| Q4 2019 | $308,000 | +41.9% | 6,413 | 0.0% | 0.08% | +26.7% |
| Q3 2019 | $217,000 | – | 6,413 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |